WallStreetZenWallStreetZen

NASDAQ: TLRY
Tilray Brands Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for TLRY

Based on 2 analysts offering 12 month price targets for Tilray Brands Inc.
Min Forecast
$3.00+74.42%
Avg Forecast
$4.00+132.56%
Max Forecast
$5.00+190.7%

Should I buy or sell TLRY stock?

Based on 2 analysts offering ratings for Tilray Brands Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 50%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their TLRY stock forecasts and price targets.

TLRY stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
TD Cowen
Bottom 15%
15
BuyMaintains$5.00+190.70%2023-04-11
Alliance Global Partners
Bottom 4%
4
HoldMaintains$3.00+74.42%2023-01-10

1 of 1

Forecast return on equity

Is TLRY forecast to generate an efficient return?
Company
5.08%
Industry
0.05%
Market
71.95%
TLRY's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is TLRY forecast to generate an efficient return on assets?
Company
3.95%
Industry
0.03%
TLRY is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

TLRY revenue growth forecast

How is TLRY forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
28.96%
Industry
8.48%
Market
8.44%
TLRY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TLRY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TLRY vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
TLRY$1.72$4.00+132.56%Buy
AVDL$14.10$19.90+41.13%Buy
ANIP$48.00$55.00+14.58%Strong Buy
AMRX$2.55$3.60+41.18%Strong Buy
COLL$21.63$32.50+50.25%Strong Buy
View Top Pharmaceutical Stocks

Tilray Brands Stock Forecast FAQ

Is Tilray Brands Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: TLRY) stock is to Buy TLRY stock.

Out of 2 analysts, 0 (0%) are recommending TLRY as a Strong Buy, 1 (50%) are recommending TLRY as a Buy, 1 (50%) are recommending TLRY as a Hold, 0 (0%) are recommending TLRY as a Sell, and 0 (0%) are recommending TLRY as a Strong Sell.

If you're new to stock investing, here's how to buy Tilray Brands stock.

What is TLRY's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: TLRY) forecast ROE is 5.08%, which is considered weak.

What is TLRY's Price Target?

According to 2 Wall Street analysts that have issued a 1 year TLRY price target, the average TLRY price target is $4.00, with the highest TLRY stock price forecast at $5.00 and the lowest TLRY stock price forecast at $3.00.

On average, Wall Street analysts predict that Tilray Brands's share price could reach $4.00 by Apr 11, 2024. The average Tilray Brands stock price prediction forecasts a potential upside of 132.56% from the current TLRY share price of $1.72.

What is TLRY's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: TLRY) forecast ROA is 3.95%, which is higher than the forecast US Drug Manufacturers - Specialty & Generic industry average of 0.03%.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.